Pharmaceutical Industry News

Christopher Martin, a stroke survivor, has made a remarkable recovery following his participation in the Neurologic Stem Cell Treatment Study. The consequences of his hemorrhagic stroke in April 2016 were terrible. Martin reports: “ I pretty much went straight into atrophy and spasticity. I could hardly do anything with my right side. My shoulder was subluxed and I wore a Kafo orthosis and a shoulder brace. I hated every minute of my life”.

One of Canada’s top research hospitals, The Ottawa Hospital, has presented results from its 2022 quality improvement study into patient outcomes after spinal surgery when using nasal photodisinfection for the prevention of surgical site infections (‘SSIs’).

PerkinElmer, Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, launched the EnVision® Nexus™ system, its fastest and most sensitive multimode plate reader to date, designed for demanding high-throughput screening (HTS) applications and to accelerate drug discovery efforts.

In a review article1 recently published in Vaccines Journal (MDPI), Dr. Carmen Ledesma-Feliciano, Scientific Affairs Manager at PharmaJet, referencing over 25 studies, discusses multiple injection delivery methods including PharmaJet’s needle-free precision delivery systems, which enhance the clinical performance of DNA-based vaccines.

The Scandinavian Biotech company, Tetra Pharm Technologies has secured €9M in a series A round led by a group of Danish investors.

Apex Labs Ltd. (APEX or the Company), a pharmaceutical company optimizing the standard of mental health care with psilocybin, is pleased to its approval by Health Canada to begin APEX-002-A01-03.

SCHOTT, the international technology group and inventor of specialty glass, maintained strong growth in the United States amid global challenges in fiscal year 2021-22.

Mobius Therapeutics™, LLC, a St. Louis-based perioperative ophthalmic pharmaceutical company, has been issued US Patent  Injection Apparatus and Method of Use.

Indee Labs is a biotechnology company developing the Hydropore™ for non-viral intracellular delivery.

In a first of its kind listing, Bruin Biometrics' pioneering Provizio® SEM Scanner Sensor for pressure injury risk detection has been made available  a covered population exceeding 1 million at-home patients.